scholarly article | Q13442814 |
P356 | DOI | 10.1089/SUR.2011.048 |
P698 | PubMed publication ID | 22439781 |
P50 | author | Niels Qvist | Q67928754 |
P2093 | author name string | Brian Warren | |
Ronald Pedersen | |||
Paul C McGovern | |||
Edward T Zito | |||
Tim Babinchak | |||
Heidi Leister-Tebbe | |||
P433 | issue | 2 | |
P921 | main subject | metronidazole | Q169569 |
ceftriaxone | Q421713 | ||
P304 | page(s) | 102-109 | |
P577 | publication date | 2012-03-22 | |
P1433 | published in | Surgical Infections | Q15765824 |
P1476 | title | Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial | |
P478 | volume | 13 |
Q60310408 | A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China |
Q38255278 | Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis |
Q47223062 | Busting the Myth of "Static vs. Cidal": A Systemic Literature Review |
Q35545954 | Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). |
Q40690093 | Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study |
Q35782490 | Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection |
Q92341709 | Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI) |
Q26797442 | Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs |
Q47129511 | Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials |
Q21146707 | Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options |
Q41243978 | Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis |
Q34057425 | Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections. |
Q38972381 | Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole |
Q47095071 | The efficacy of combined therapy with metronidazole and broad-spectrum antibiotics on postoperative outcomes for pediatric patients with perforated appendicitis |
Search more.